Our operating rooms are equipped with the most advanced technology, allowing us to do minimally invasive surgery and imaging during operations. The View Hospital is also equipped with the Da Vinci and ...

Artis zee Magnetic Navigation systems have been specifically designed for compatibility with the Stereotaxis NIOBE® Magnetic Navigation system. Available as a floor-mounted or biplane system with ...

The RAV4 might go hybrid-only for 2026 ... which should afford extra cargo room behind the second row. The RAV4 retains the trapezoidal wheel arches of the current iteration, while the taillights ...

The ACUSON X300™ ultrasound system, premium edition (PE) — Women’s Imaging is a compact, all-digital ultrasound system delivering exceptional clinical performance, automated workflow ...

With the ICE and electric drive systems operating in harmony, the 350e felt smooth and effortlessly powerful. While I did detect some hesitation when switching between various EV, hybrid ...

Rome Health is building a hybrid operating room that will allow surgeons to do some advanced surgeries that can’t be done in the hospital’s other operating rooms. The hybrid OR, made possible ...

The RAV4 specifically uses the TNGA-K version. We won’t be surprised if Toyota goes hybrid-only with the new RAV4, as it has with the Camry mid-size sedan. In fact, we expect the RAV4 to share ...

Siemens Energy in 'sweet spot' in U.S. market Siemens Energy chairperson: AI has led to power sector boom Siemens Energy shares hit new record after comments Shares in Siemens Energy, which makes ...

This funding will contribute to the establishment of a hybrid operating room, as part of a broader initiative to upgrade the hospital’s outdated operating rooms and intensive care unit. The Kaplan ...

The funds will help transform one of the new operating rooms into a hybrid room capability of handling larger and more complex surgeries. (Photo credit: Oneida County) ROME, N.Y. — Oneida County on ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in ...